Dr. Aaron Schwartz
Dr. Aharon Schwartz has been a member of the company’s board of directors since November 2014. He had a distinguished career at Teva Pharmaceuticals spanning nearly four decades, where he served in various senior executive positions until his retirement in 2011, with his most recent role being Vice President, Head of Teva Innovative Ventures. From January 2013 through November 2017, he served as a member of the board of directors of Alcobra Ltd. Dr. Schwartz is currently Chairman of the board of BiolineRx Ltd., and a member of the board of directors of Barcode Ltd. Dr. Schwartz received a Ph.D. in organic chemistry from the Weizmann Institute of Science, and a Ph.D. from the Hebrew University of Jerusalem in the history and philosophy of science. He also received an M.Sc. in organic chemistry from Technion, and a B.Sc. in chemistry and physics from the Hebrew University of Jerusalem.